Infant Bacterial Therapeutics
Annual Report 2023

Loading PDF...

More annual reports from Infant Bacterial Therapeutics:

2023 Report
2022 Report
2021 Report
2020 Report
2019 Report

Share your feedback:


Peers and competitors of Infant Bacterial Therapeutics:

Pires Investments plc
Neuberger Berman
OCI
The Westaim Corporation
Cambria Africa plc